← FDA Drug Approvals (Drugs@FDA)
POSACONAZOLE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HETERO LABS LTD III · Approved 2022-12-08
Drug application
- FDA Application #
ANDA214321- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- POSACONAZOLE
- Generic name
- POSACONAZOLE
- Active ingredients
- POSACONAZOLE
- Dosage form
- TABLET, DELAYED RELEASE
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- HETERO LABS LTD III
- Manufacturer
- NorthStar RxLLC
- First approval
- 2022-12-08
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown